Catlin James R, Adams Christopher B, Louie Daniel J, Wilson Machelle D, Louie Erin N
1 University of California, Davis Medical Center, Sacramento, CA, USA.
Ann Pharmacother. 2018 Jan;52(1):26-31. doi: 10.1177/1060028017725763. Epub 2017 Aug 8.
Intravenous (IV) loop diuretics are recommended to relieve vascular congestion in patients with acute decompensated heart failure (ADHF); however, initial dosing is often empirical. Strong evidence supporting individualized diuretic dosing in the emergency department (ED) is lacking.
The purpose of this study was to compare the efficacy and safety of aggressive (≥2 daily home doses) and conservative (<2 daily home doses) initial doses of loop diuretic.
This was a retrospective cohort study in adult patients presenting to the ED with ADHF at an academic medical center from Apri 2015 to September 2015. The primary outcome was time to transition from IV to oral diuretics.
A total of 91 patients were included (aggressive dosing, n = 44; conservative dosing, n = 47). Mean time to transition from IV to oral diuretics was 67.9 hours in the aggressive group compared with 88.1 hours in the conservative group ( P = 0.049). Mean hospital length of stay (LOS) was 119.5 hours in the aggressive group versus 123.0 hours in the conservative group ( P = 0.799). No differences were observed between the mean urine output ( P = 0.829), change in body weight ( P = 0.528), or serum creatinine ( P = 0.135).
Patients who received an aggressive initial diuretic dose in the ED had a significantly faster time to oral diuretic therapy without any significant differences in hospital LOS, urine output, change in body weight, and renal function when compared with conservative dosing.
静脉注射襻利尿剂被推荐用于缓解急性失代偿性心力衰竭(ADHF)患者的血管充血;然而,初始剂量通常是经验性的。缺乏支持急诊科(ED)进行个体化利尿剂给药的有力证据。
本研究的目的是比较襻利尿剂激进初始剂量(≥每日家庭剂量的2倍)和保守初始剂量(<每日家庭剂量的2倍)的疗效和安全性。
这是一项回顾性队列研究,研究对象为2015年4月至2015年9月在一家学术医疗中心急诊科就诊的成年ADHF患者。主要结局是从静脉利尿剂过渡到口服利尿剂的时间。
共纳入91例患者(激进给药组,n = 44;保守给药组,n = 47)。激进组从静脉利尿剂过渡到口服利尿剂的平均时间为67.9小时,而保守组为88.1小时(P = 0.049)。激进组的平均住院时间(LOS)为119.5小时,保守组为123.0小时(P = 0.799)。平均尿量(P = 0.829)、体重变化(P = 0.528)或血清肌酐(P = 0.135)之间未观察到差异。
与保守给药相比,在急诊科接受激进初始利尿剂剂量的患者口服利尿剂治疗的时间显著更快,且在住院时间、尿量、体重变化和肾功能方面无显著差异。